You are here: Industry Insights > COVID-19

News List

Mexico may not follow FDA and approve remdesivir for COVID-19 expresspharma
October 26, 2020
WHO Solidarity drug trial last week concluded remdesivir has little or no impact on a patient’s chances of surviving COVID-19.
Home State Health Urges Breast Cancer Screenings After Delays Due to COVID-19 Pandemic prnewswire
October 23, 2020
As healthcare facilities across Missouri resume scheduling routine appointments and screenings, Home State Health wants to remind communities of the importance of taking care of their health.
TrippBio Announces the Completion of Enrollment in a Proof of Concept Clinical Trial Evaluating the Efficacy of TD213 in Treating Patients with Confirmed COVID-19 Infections prnewswire
October 23, 2020
?TrippBio is a biotechnology company dedicated to developing groundbreaking treatments for viral infections initially targeting the global pandemic caused by COVID-19.
Study finds tocilizumab improves survival in critically ill patients with COVID-19 worldpharmanews
October 23, 2020
Researchers from 68 sites across the country, led by David E. Leaf, MD, MMSc and Shruti Gupta, MD, MPH from the Division of Renal Medicine at Brigham and Women's Hospital, have investigated the effects of the anti-inflammatory drug tocilizumab on ...
Moderna completes enrollment of Phase 3 COVE study of mRNA vaccine against COVID-19 (mRNA-1273) worldpharmanews
October 23, 2020
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, announced that it has completed enrollment of 30,000 participants for the Phase 3 COVE...
FDA approves first treatment for COVID-19 worldpharmanews
October 23, 2020
The U.S. Food and Drug Administration approved the antiviral drug Veklury (remdesivir) for use in adult and pediatric patients 12 years of age and older and weighing at least 40 kilograms (about 88 pounds) for the treatment of COVID-19 requiring hospitali
Centogene Receives EUA for SARS-CoV-2 RT-PCR Assay americanpharmaceuticalreview
October 23, 2020
Centogene announced the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for CentoSure, the company's latest SARS-CoV-2 RT-PCR test.
DxTerity Announces New At-Home COVID-19 Testing Solution americanpharmaceuticalreview
October 23, 2020
DxTerity Diagnostics announced the U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA 202120) for their SARS-CoV-2 RT-PCR test, SafeWorkDx?.
Aridis Reports Positive Preclinical Efficacy Data for Inhaled Treatment for COVID-19 americanpharmaceuticalreview
October 23, 2020
Aridis Pharmaceuticals announced the development of a highly neutralizing monoclonal antibody AR-711, discovered from convalescent COVID-19 patients that successfully eliminated all detectable SARS-CoV-2 virus in infected animals at ...
Roche, Atea Pharma to Develop Potential Oral COVID-19 Treatment contractpharma
October 23, 2020
?Roche and Atea Pharmaceuticals, Inc. have partnered to develop, manufacture and distribute AT-527, Atea’s investigational oral direct-acting antiviral, to treat COVID-19.